Six months after receiving US Food and Drug Administration 510(k) clearance for its SC+ portable hemodialysis system for use in acute and chronic care facilities, Quanta Dialysis Technologies Ltd has raised $245m in a series D financing to help “turbocharge its business,” according to Quanta CEO John Milad.
“The main focus of [using] the proceeds will be to ramp up our UK and European commercialization [following the second CE mark in 2019 for its second-generation hemodialysis device), to...